Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age32-42
SponsorSunkaky Medical Cooperation

About this trial

The objective of this study is to investigate the efficacy of NMN supplementation in enhancing embryo developmental capacity and improving IVF success rates in patients experiencing IVF failures.

Eligibility criteria

Qualifiers

Agree to participate in the study

32-42 years old

Having at least one previous embryo implantation failure

History of low Embryo quality at day3 or day5 (according to Veeck's and Gardner's Criteria)

Disqualifiers

Ovarian endometriosis with Chocolate cysts (AFS type 3 and 4)

Patients who have taken different supplements such as coenzyme Q10, vitamin E, carnitine,niacin, nicotinamide, or other vitamin B3-related etc. within the previous month

Any medical contraindication of oocyte retrieval or subsequent procedures

Couples where the husband presents with severe sperm abnormalities

Trial design

Treatments tested in this trial

  • NMN capsule
  • Placebo

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Sunkaky Medical Cooperation

Lead sponsor

Abinopharm, Inc

Collaborator

Aba Chemicals Co Ltd

Collaborator